Evidence map›Paper›PMID 33275517›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2021

Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.

Anissa Viveiros, Jaslyn Rasmuson, Jennie Vu, Sharon L Mulvagh, Cindy Y Y Yip, Colleen M Norris, Gavin Y Oudit

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 4 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 4 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Innate immunity to SARS-CoV-2 infection: a review.Epidemiology and infection · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Anissa ViveirosDepartment of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Jaslyn RasmusonDepartment of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Jennie VuDepartment of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Sharon L MulvaghDivision of Cardiology, Dalhousie University, Halifax, Canada.
Cindy Y Y YipHeart and Stroke Foundation of Canada, Toronto, Canada.
Colleen M NorrisDivision of Cardiology, Dalhousie University, Halifax, Canada.
Gavin Y OuditDivision of Cardiology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
University of Alberta · CADalhousie University · CAHeart and Stroke Foundation · CAMayo Clinic · US

Funding

Gouvernement du Canada | CIHR | Institute of Health Services and Policy Research (IHSPR)Heart and Stroke Foundation of Canada (HSF)
6 · The paper itself

Abstract

Biological sex is increasingly recognized as a critical determinant of health and disease, particularly relevant to the topical COVID-19 pandemic caused by the SARS-CoV-2 coronavirus. Epidemiological data and observational reports from both the original SARS epidemic and the most recent COVID-19 pandemic have a common feature: males are more likely to exhibit enhanced disease severity and mortality than females. Sex differences in cardiovascular disease and COVID-19 share mechanistic foundations, namely, the involvement of both the innate immune system and the canonical renin-angiotensin system (RAS). Immunological differences suggest that females mount a rapid and aggressive innate immune response, and the attenuated antiviral response in males may confer enhanced susceptibility to severe disease. Furthermore, the angiotensin-converting enzyme 2 (ACE2) is involved in disease pathogenesis in cardiovascular disease and COVID-19, either to serve as a protective mechanism by deactivating the RAS or as the receptor for viral entry, respectively. Loss of membrane ACE2 and a corresponding increase in plasma ACE2 are associated with worsened cardiovascular disease outcomes, a mechanism attributed to a disintegrin and metalloproteinase (ADAM17). SARS-CoV-2 infection also leads to ADAM17 activation, a positive feedback cycle that exacerbates ACE2 loss. Therefore, the relationship between cardiovascular disease and COVID-19 is critically dependent on the loss of membrane ACE2 by ADAM17-mediated proteolytic cleavage. This article explores potential mechanisms involved in COVID-19 that may contribute to sex-specific susceptibility focusing on the innate immune system and the RAS, namely, genetics and sex hormones. Finally, we highlight here the added challenges of gender in the COVID-19 pandemic.

Indexed as

ADAM17 ProteinAdaptive ImmunityAndrogensAngiotensin-Converting Enzyme 2Cardiovascular DiseasesCOVID-19EstrogensFemaleGenes, X-LinkedHumansImmunity, InnateMalePromoter Regions, GeneticReceptors, CoronavirusRenin-Angiotensin SystemResponse ElementsADAM17 ProteinAndrogensAngiotensin-Converting Enzyme 2EstrogensReceptors, CoronavirusACE2cardiovascular diseasegenderSARS-CoV-2sexsex differences

Identifiers

PMID33275517
PMCPMC8083171
OpenAlexW3109354304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.